Accordingly, we found that inhibiting Tpm3.1/3.2 function with ATM-3507 reduced leading-edge membrane protrusion and the 2D motility of DLBCL cells on FN substrates as well as their chemotaxis toward CXCL12. The gene discussed is ATM; the disease is diffuse large B-cell lymphoma.